Metabolic changes in myometrium associated with adenomyosis revealed by liquid chromatography–tandem mass spectrometry-based high-throughput targeted lipid quantitative profiling
Reproductive BioMedicine Online · 2025-08 · 51 (2) · 104861
DOI: 10.1016/j.rbmo.2025.104861 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Reproductive BioMedicine Online, 2025-08. Verfasst von Liang Qian und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Hangzhou Women's Hospital (Hangzhou Maternity and Child Health Care Hospital), Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Adenomyosis, Myometrium, Lipid Metabolism, Lipids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
RESEARCH QUESTION: What are the lipidomic alterations in the myometrial tissue from adenomyotic lesions? DESIGN: This was a two-centre, prospective, observational study conducted between July 2023 and June 2024. Forty-four premenopausal patients were enrolled: 22 patients with adenomyosis confirmed by post-operative pathology and 22 control participants undergoing hysterectomy for benign conditions without adenomyosis. Myometrial tissue samples were collected during surgery, and lipid extraction performed by liquid-liquid extraction and lipidomic profiling carried out using a liquid chromatography-tandem mass spectrometry platform. Data analysis included multivariate statistical methods, such as principal component analysis and orthogonal partial least squares discriminant analysis, to identify lipid metabolites differentially expressed between the adenomyosis and control groups. RESULTS: A total of 1100 lipid species were identified, with 84 showing significant differences between adenomyosis patients and control participants. Of these, 76 lipids were upregulated and eight were down-regulated. The highest differentially expressed lipid content was mainly concentrated in glyceropholipids, with notable alterations in acylcarnitines and lysophosphatidylcholines. CONCLUSION: This study reveals significant lipidomic changes in adenomyosis, with upregulated acylcarnitines and elevated lysophosphatidylcholines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecology, Hangzhou Women's Hospital (Hangzhou Maternity and Child Health Care Hospital), Hangzhou, Zhejiang, China.
- Department of Obstetrics and Gynecology, Anqing Hospital Affiliated to Anhui Medical University, Anqing, Anhui, China.
- Department of Pathology, Hangzhou Women's Hospital (Hangzhou Maternity and Child Health Care Hospital), Hangzhou, Zhejiang, China.
- Department of Gynecology, Hangzhou Women's Hospital (Hangzhou Maternity and Child Health Care Hospital), Hangzhou, Zhejiang, China. Electronic address: lidh2016@126.com.
Zitieren
APA
Qian, L., Wang, G., Chen, H., Li, Q., Chen, F., Liu, W., Wang, D., Xu, H., Qian, Z., & Li, D. (2025). Metabolic changes in myometrium associated with adenomyosis revealed by liquid chromatography–tandem mass spectrometry-based high-throughput targeted lipid quantitative profiling. Reproductive BioMedicine Online, 51(2), 104861. https://doi.org/10.1016/j.rbmo.2025.104861
Vancouver
Qian L, Wang G, Chen H, Li Q, Chen F, Liu W, et al. Metabolic changes in myometrium associated with adenomyosis revealed by liquid chromatography–tandem mass spectrometry-based high-throughput targeted lipid quantitative profiling. Reproductive BioMedicine Online. 2025;51(2):104861. doi:10.1016/j.rbmo.2025.104861
BibTeX
@article{Qian2025,
author = {Qian, Liang and Wang, Gensheng and Chen, Hao and Li, Qing and Chen, Feng and Liu, Wenhua and Wang, Dan and Xu, Hongling and Qian, Ziqiang and Li, Dingheng},
title = {Metabolic changes in myometrium associated with adenomyosis revealed by liquid chromatography–tandem mass spectrometry-based high-throughput targeted lipid quantitative profiling},
journal = {Reproductive BioMedicine Online},
year = {2025},
volume = {51},
number = {2},
pages = {104861},
doi = {10.1016/j.rbmo.2025.104861}
}
EUVIMED